Shree Ganesh Remedies Limited (BOM:540737)

Market Cap	5.43B
Revenue (ttm)	1.01B
Net Income (ttm)	180.82M
Shares Out	12.84M
EPS (ttm)	14.08
PE Ratio	30.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,636
Average Volume	4,117
Open	410.05
Previous Close	403.05
Day's Range	410.05 - 430.00
52-Week Range	399.95 - 950.00
Beta	-0.06
RSI	43.84
Earnings Date	Jan 23, 2026

About Shree Ganesh Remedies

Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty c...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1995
• Employees: 149
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540737

Financial Performance

In 2024, Shree Ganesh Remedies's revenue was 1.09 billion, a decrease of -13.74% compared to the previous year's 1.26 billion. Earnings were 230.68 million, a decrease of -17.93%.